AML study correlates gene mutations with 34 disease subgroups

March 21, 2017, Ohio State University Medical Center
Bone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: Wikipedia

A large, new study of adults with acute myeloid leukemia (AML) correlates 80 cancer-related gene mutations with five subtypes of AML, which are defined by the presence of specific chromosomal abnormalities. The findings might help guide mutation testing and treatment decisions in the future.

Led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), the study involved 1,603 newly diagnosed adult AML patients, who were treated on Cancer and Leukemia Group B/Alliance for Clinical Trials in Oncology trials in multiple centers across the United States .

The researchers combined the cytogenetic abnormalities that define each of 34 AML subgroups with the mutation status of the 80 cancer-related to produce an "oncoprint," a compact tabular summary of the gene associated with each cytogenetic group.

Reported in the journal Leukemia, the findings identify:

  • Potentially important genetic differences among the 34 subgroups;
  • Unexpected associations between the AML subsets and both specific gene mutations and gene functional groups;
  • Significant differences in cytogenetic and mutational features between patients younger than 60 years of age and those 60 years and older;

"Our study summarizes cytogenetic and mutational information of 1,603 AML patients in a single image," says first author and OSUCCC - James researcher Ann-Kathrin Eisfeld, MD, a member of Ohio State's Internal Medicine/Physician-Scientist Training Program. "The identification of key mutational features of each subgroup may help us to better understand the pathogenesis of the different AML types and provides a wealth of information for ongoing and future research."

Senior investigator Clara D. Bloomfield, MD, Distinguished University Professor, Ohio State University Cancer Scholar and Senior Adviser to the OSUCCC - James, adds: "If our findings are confirmed, it may mean that our mutational oncoprint may help to guide mutation testing and potentially even future treatment decisions for patients."

For this study, Eisfeld, Bloomfield and their colleagues obtained pretreatment bone marrow or peripheral blood samples from each patient. Of the patients, 1,080 were under age 60, and 523 were 60 years or older. All received similar treatment through Cancer and Leukemia Group B clinical trials.

Each patient's diagnosis placed him or her into one of five AML types and one of 34 subgroups, according to the presence or absence of specific chromosomal abnormalities in the person's leukemic cells. (AML patients with no chromosomal abnormalities are classified as having cytogenetically normal AML [CN-AML].)

The patients' leukemic cells were sequenced to learn the mutational status of 80 cancer- and leukemia-related genes. The mutations were assigned to one of nine categories based on the gene's biological function (e.g., methylation-related, cohesin complex, chromatin remodeling, tumor-suppressor genes).

The researchers identified 4,390 gene mutations in the patient cohort, with a median three mutations per patient. Overall, the most frequently mutated genes that contributed to AML in this cohort belonged to the methylation group.

Key genetic differences revealed by the mutational oncoprint include:

  • A high incidence of mutations in methylation-related genes in patients with CN-AML, complex karyotype AML or unbalanced abnormalities;
  • In contrast, mutations in methylation-related genes were almost absent in core-binding factor AML (CBF-AML) patients or were rather rare in patients with non-CBF-AML-related balanced translocations or inversions.
  • Mutations in spliceosome genes were frequent in with unbalanced chromosomal abnormalities, especially those with sole trisomy of chromosomes 4, 8, 11, 13 or 21.

Explore further: Two genetic mutations discovered in subset of acute myeloid leukemia

More information: A-K Eisfeld et al, The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia, Leukemia (2017). DOI: 10.1038/leu.2017.86

Related Stories

Two genetic mutations discovered in subset of acute myeloid leukemia

December 7, 2016
Two genetic mutations known to play a role in many solid cancers might also help explain why a subset of acute myeloid leukemia (AML) patients develop the disease, according to new research from The Ohio State University ...

AML score that combines genetic and epigenetic changes might help guide therapy

January 7, 2014
(Medical Xpress)—Currently, doctors use chromosome markers and gene mutations to determine the best treatment for a patient with acute myeloid leukemia (AML). But a new study suggests that a score based on seven mutated ...

Gene mutation signals a high risk of recurrence in some older acute-leukemia patients

December 12, 2011
Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, according to a new study by researchers at the ...

One in five breast cancer patients could benefit from existing treatment, genetic study reveals

March 13, 2017
Researchers from the Wellcome Trust Sanger Institute and their collaborators have discovered that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes. The results published ...

Research leads to new treatment recommendations for a high-risk pediatric leukemia

January 23, 2017
Research led by St. Jude Children's Research Hospital has identified three genetic alterations to help identify high-risk pediatric patients with acute megakaryoblastic leukemia (AMKL) who may benefit from allogeneic stem ...

Researchers reveal genomic landscape of core-binding factor acute myeloid leukemia

October 31, 2016
An international team of researchers from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP) has completed a detailed map of the genomic landscape for core-binding factor ...

Recommended for you

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...

Cancer cells co-opt pain-sensing 'wasabi receptor' to survive oxidative stress

May 24, 2018
Anyone who's taken a bite of a sandwich with too much spicy mustard or a piece of sushi with too much wasabi can attest to the tear-inducing sensation these condiments can cause. These loud warnings to the nervous system ...

Tumor cells evade death through in extremis DNA repair

May 24, 2018
Greater knowledge of the mechanisms that contribute to the survival of tumour cells is key to vanquishing them. The study published today in the journal Cancer Cell, headed by Angel R. Nebreda, ICREA researcher at the Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.